Global POC Blood Glucose Monitoring Devices Market 2018-2022

◆상품코드 : IRTNTR21495
◆발행일 : 2018년 2월
◆페이지수 : 130
◆보고서 형식 : 一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど) / 영문
◆납품 방식 : Email
◆조사대상 지역 : 글로벌
◆산업분야 : 미분류
◆발행회사(조사회사) : Technavio
◆판매회사 : H&I글로벌리서치(주)
◆판매가격 옵션
Single User¥ -> 환산 ₩원화 가격은 문의주세요.견적의뢰/구매/질문FORM
Five User¥ -> 환산 ₩원화 가격은 문의주세요.견적의뢰/구매/질문FORM
Enterprise License¥ -> 환산 ₩원화 가격은 문의주세요.견적의뢰/구매/질문FORM
※지불하실 금액은 상기금액이며, 세금 및 배송료는 없습니다.
※지불은 선불결제 방식이며, 신용카드결제 또는 계좌입금(국내/해외)이 선택가능합니다.
※구매의사를 FORM기입 또는 E메일로 연락주시면 담당자가 회신 드리겠습니다.
※배송은 입금 확인 후, E메일로 납품드리며, 일반적으로 당일~2일정도 소요됩니다.
※가격옵션 설명 : (Single User : 귀사내에서 1명만 사용가능 / Five User, Multi User : 귀사내에서 5명까지 사용가능 / Site License, Corporate License : 동일국내에서 인원제한없이 사용가능 / Global Site License, Enterprise License : 지역상관없이 인원제한없이 사용/공유 가능한 라이센스). 자세한 설명은 이용안내 페이지를 참고하세요.


[조사보고서 개요]

About POC Blood Glucose Monitoring Devices
POC blood glucose monitoring devices are portable, near-patient devices that allow the immediate detection of glucose levels in a patient and facilitate rapid treatment solutions if the need arises. These devices consist of minimum operator interaction and are non-invasive in nature with efficient data management and connectivity tools.

Technavio’s analysts forecast the global POC blood glucose monitoring devices market to grow at a USD 2,036.4 million during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global POC blood glucose monitoring devices market for 2018-2022. To calculate the market size, the report considers the revenue generated from the POC blood glucose monitoring devices.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global POC Blood Glucose Monitoring Devices Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Abbott
• ARKRAY
• Ascensia Diabetes Care
• Danaher
• F. Hoffmann-La Roche
• Johnson & Johnson

[Market driver]
• Public and private initiatives to reduce diabetic cases
• For a full, detailed list, view our report

[Market challenge]
• High cost associated with diabetes management
• For a full, detailed list, view our report

[Market trend]
• Paradigm shift towards non-invasive products
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

[조사보고서 목차]

Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT
• Segmentation by product
• Comparison by product
• Consumables
• Instruments
• Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY END-USER
• Segmentation by end-user
• Hospitals and clinics
• Clinical diagnostic laboratories
• Home care settings

PART 10: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• POC blood glucose monitoring devices market in Americas
• POC blood glucose monitoring devices market in EMEA
• POC blood glucose monitoring devices market in APAC
• Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 13: MARKET TRENDS
• Paradigm shift towards non-invasive products
• Increase in online product sales
• Product bundling

PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive landscape

PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• ARKRAY
• Ascensia Diabetes Care
• Danaher
• F. Hoffmann-La Roche
• Johnson & Johnson
• Other prominent vendors
• List of abbreviations

[List of Exhibits] Exhibit 01: Parent market
Exhibit 02: Global IVD market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global – Year over year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2017
Exhibit 18: Global POC blood glucose monitoring devices by Product – Market share 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Consumables – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Product 1 – Year over year growth 2018-2022 (%)
Exhibit 22: Product 2 – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Product 2 – Year over year growth 2018-2022 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Global POC blood glucose monitoring devices market by end-user – Market share 2027 (%)
Exhibit 27: Global POC blood glucose monitoring devices – Market share by geography 2017-2022 (%)
Exhibit 28: Regional comparison
Exhibit 29: POC blood glucose monitoring devices market in the Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 30: POC blood glucose monitoring devices market in the Americas – Year over year growth 2018-2022 (%)
Exhibit 31: Top 3 countries in Americas
Exhibit 32: POC blood glucose monitoring devices market in EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 33: POC blood glucose monitoring devices market in EMEA – Year over year growth 2018-2022 (%)
Exhibit 34: Top 3 countries in EMEA
Exhibit 35: POC blood glucose monitoring devices market in APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 36: POC blood glucose monitoring devices market in APAC – Year over year growth 2018-2022 (%)
Exhibit 37: Top 3 countries in APAC
Exhibit 38: Global POC blood glucose monitoring devices market opportunity
Exhibit 39: Various programs to reduce cost burden for diabetics
Exhibit 40: Vendor landscape
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Landscape disruption
Exhibit 44: Competitive structure analysis of global POC blood glucose monitoring devices market 2016
Exhibit 45: Vendors covered
Exhibit 46: Vendors covered
Exhibit 47: Vendor classification
Exhibit 48: Vendor classification
Exhibit 49: Market positioning of vendors
Exhibit 50: Market positioning of vendors
Exhibit 51: Abbott overview
Exhibit 52: Abbott – Business segments
Exhibit 53: Abbott – Organizational developments
Exhibit 54: Abbott – Geographic focus
Exhibit 55: Abbott– Segment focus
Exhibit 56: Abbott – Key offerings
Exhibit 57: Abbott – Key customers
Exhibit 58: ARKRAY overview
Exhibit 59: ARKRAY – Business segments
Exhibit 60: ARKRAY – Organizational developments
Exhibit 61: ARKRAY– Geographic focus
Exhibit 62: ARKRAY– Segment focus
Exhibit 63: ARKRAY – Key offerings
Exhibit 64: ARKRAY– Key customers
Exhibit 65: Ascensia Diabetes Care overview
Exhibit 66: Ascensia Diabetes Care– Business segments
Exhibit 67: Ascensia Diabetes Care – Organizational developments
Exhibit 68: Ascensia Diabetes Care – Geographic focus
Exhibit 69: Ascensia Diabetes Care – Segment focus
Exhibit 70: Ascensia Diabetes Care – Key offerings
Exhibit 71: Ascensia Diabetes Care – Key customers
Exhibit 72: Danaher overview
Exhibit 73: Danaher – Business segments
Exhibit 74: Danaher – Organizational developments
Exhibit 75: Danaher – Geographic focus
Exhibit 76: Danaher – Segment focus
Exhibit 77: Danaher– Key offerings
Exhibit 78: Danaher– Key customers
Exhibit 79: F. Hoffmann-La Roche overview
Exhibit 80: F. Hoffmann-La Roche – Business segments
Exhibit 81: F. Hoffmann-La Roche– Organizational developments
Exhibit 82: F. Hoffmann-La Roche – Geographic focus
Exhibit 83: F. Hoffmann-La Roche – Segment focus
Exhibit 84: F. Hoffmann-La Roche – Key offerings
Exhibit 85: F. Hoffmann-La Roche – Key customers
Exhibit 86: Vendor overview
Exhibit 87: Vendor 1 – Business segments
Exhibit 88: Vendor 1 – Organizational developments
Exhibit 89: Vendor 1 – Geographic focus
Exhibit 90: Vendor 1 – Segment focus
Exhibit 91: Vendor 1 – Key offerings
Exhibit 92: Vendor 1 – Key customers



[조사보고서에 언급된 기업]
PDF

[보고서에 포함된 내용]
세계시장규모, 세그멘트별 시장규모, 시장동향, 시장예측, 관련 기업정보 등

[면책사항]
http://www.globalresearch.kr/disclaimer

★조사보고서 [Global POC Blood Glucose Monitoring Devices Market 2018-2022]에 관해서 E메일 문의 연락
◆H&I글로벌리서치의 고객기업(예)◆